We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microphysiometer Can Assess Bioterrorism Agents

By Biotechdaily staff writers
Posted on 19 Jan 2004
A new device that monitors the metabolism of living cells in near real-time can analyze and defend against novel bioterrorism agents.

The device is a four-channel microphysiometer, a modification of an older device called the Cytosensor that measures changes in acidity in a small chamber holding between 100,000-1,000,000 individual cells. Researchers have added three additional sensors so they can simultaneously chart minute-by-minute variations in the concentrations of oxygen, glucose, and lactic acid, in addition to pH. This is important since the basic metabolism of a cell involves consuming oxygen and glucose and producing lactic and carbonic acid. So monitoring variations in these four chemicals allows researchers to quickly assess the impact that exposure to different chemicals have on the activity and health of small groups of cells.

In addition to its potential application for bioterrorism, the microphysiometer has potential applications in detecting and assessing the toxicity of environmental pollutants. The device consists of a series of reservoirs, switches, rotary pumps, and tiny chambers made from two thin membrane sheets that contain the cell colonies. The researchers have been using the device to study cell response to a number of different chemical and biologic agents, including pesticides and pollutants.

"So far we have been lucky that terrorists have used well-known biologic agents like anthrax and sarin gas,” said David Cliffel, assistant professor of chemistry at Vanderbilt University (Nashville, TN, USA; www.vanderbilt.edu), who led the development group. But how will we respond if one of these groups uses recent advances in genetic engineering to produce an agent that is new and unknown?”

Vanderbilt >> www.vanderbilt.edu

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Manual Pipetting Aid
Pipette Controllers macro
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
19 Jan 2004  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
19 Jan 2004  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
19 Jan 2004  |   BioResearch